Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker
MicroRNAs (miRNAs) have a large number of various target genes in different cancer types, which may result in many biological functions. Thus, identifying the molecular mechanisms of miRNAs may effect on the complexity of cancer progression via regulation of gene. In the current study, we utilized r...
Gespeichert in:
Veröffentlicht in: | Tumor biology 2016-05, Vol.37 (5), p.5765-5768 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5768 |
---|---|
container_issue | 5 |
container_start_page | 5765 |
container_title | Tumor biology |
container_volume | 37 |
creator | Ziari, Katayoun Zarea, Mojtaba Gity, Masoumeh Fayyaz, Amir Farshid Yahaghi, Emad Darian, Ebrahim Khodaverdi Hashemian, Amir Masoud |
description | MicroRNAs (miRNAs) have a large number of various target genes in different cancer types, which may result in many biological functions. Thus, identifying the molecular mechanisms of miRNAs may effect on the complexity of cancer progression via regulation of gene. In the current study, we utilized real-time PCR to quantify the diction of miR-148b in trail hepatocellular carcinoma (HCC) specimen and normal tissues. Furthermore, we evaluated the relationship of miR-148b and clinicopathological features with survival of HCC patients. Therefore, we evaluated the level of miR-148b expression in 101 HCC patients and also in 40 normal control cases. The result suggested lower expression in tumor tissues than normal control tissues (0.96 ± 0.14; 1.84 ± 0.20, P |
doi_str_mv | 10.1007/s13277-015-3777-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790463685</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4062893181</sourcerecordid><originalsourceid>FETCH-LOGICAL-p239t-f5a9e7922b364df2ceaa0ef045d2284f87579024ec67253ce5047bcaef73d9703</originalsourceid><addsrcrecordid>eNpdkMtOwzAQRS0EoqXwAWyQJTZsAn7G8RKVp1QJCcE6cpxJSUniYCegSnw8LrQbVnMXZ47uDEKnlFxSQtRVoJwplRAqE65iEHtoSgXjCeEZ2Y-ZUJIIlvEJOgphRSKodXqIJixlJBU6m6LvG_fVeViOjRlq12FX4bZ-TqjICmwCLmrXGv8OHlfOYzC-WeMSBrA7-A16MzgLTRMNHlvjbd3FHWy6ErdmjQP4T9ioDO69W3YuDLXFf9JjdFCZJsDJds7Q693ty_whWTzdP86vF0nPuB6SShoNSjNW8FSUFbNgDIGKCFkylokqU1JpwgTYVDHJLUgiVGENVIqXWhE-Qxd_3tjgY4Qw5G0dNp1NB24MOY3rIuVpJiN6_g9dudF3sd0vRSVXekOdbamxaKHMe1_Hi9b57q_8B89kesE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1790153795</pqid></control><display><type>article</type><title>Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker</title><source>SpringerLink Journals - AutoHoldings</source><creator>Ziari, Katayoun ; Zarea, Mojtaba ; Gity, Masoumeh ; Fayyaz, Amir Farshid ; Yahaghi, Emad ; Darian, Ebrahim Khodaverdi ; Hashemian, Amir Masoud</creator><creatorcontrib>Ziari, Katayoun ; Zarea, Mojtaba ; Gity, Masoumeh ; Fayyaz, Amir Farshid ; Yahaghi, Emad ; Darian, Ebrahim Khodaverdi ; Hashemian, Amir Masoud</creatorcontrib><description>MicroRNAs (miRNAs) have a large number of various target genes in different cancer types, which may result in many biological functions. Thus, identifying the molecular mechanisms of miRNAs may effect on the complexity of cancer progression via regulation of gene. In the current study, we utilized real-time PCR to quantify the diction of miR-148b in trail hepatocellular carcinoma (HCC) specimen and normal tissues. Furthermore, we evaluated the relationship of miR-148b and clinicopathological features with survival of HCC patients. Therefore, we evaluated the level of miR-148b expression in 101 HCC patients and also in 40 normal control cases. The result suggested lower expression in tumor tissues than normal control tissues (0.96 ± 0.14; 1.84 ± 0.20, P < 0.05). Our findings suggest that the declined expression of miR-148b can considerably be linked to tumor node metastasis (TNM) stage (stages III and IV; P = 0.021) and vein invasion (P = 0.029). Nevertheless, miR-148b expression was not related to sex (P = 0.674), age (P = 0. 523), size of tumor (P = 0.507), liver cirrhosis, and histologic grade (P = 0.734). Survival analysis showed that low expression was remarkably related to overall survival (P = 0.012). Furthermore, multivariate survival test suggested that decline of miR-148b diction was linked to poor survival in HCC patients. Our results suggested that miR-148b is decreased in HCC. Therefore, we concluded that miR-148b may play its role in the prognosis of HCC.</description><identifier>ISSN: 1010-4283</identifier><identifier>EISSN: 1423-0380</identifier><identifier>DOI: 10.1007/s13277-015-3777-4</identifier><identifier>PMID: 26206498</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Biomarkers ; Liver cancer ; MicroRNAs ; Pathology</subject><ispartof>Tumor biology, 2016-05, Vol.37 (5), p.5765-5768</ispartof><rights>International Society of Oncology and BioMarkers (ISOBM) 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26206498$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ziari, Katayoun</creatorcontrib><creatorcontrib>Zarea, Mojtaba</creatorcontrib><creatorcontrib>Gity, Masoumeh</creatorcontrib><creatorcontrib>Fayyaz, Amir Farshid</creatorcontrib><creatorcontrib>Yahaghi, Emad</creatorcontrib><creatorcontrib>Darian, Ebrahim Khodaverdi</creatorcontrib><creatorcontrib>Hashemian, Amir Masoud</creatorcontrib><title>Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker</title><title>Tumor biology</title><addtitle>Tumour Biol</addtitle><description>MicroRNAs (miRNAs) have a large number of various target genes in different cancer types, which may result in many biological functions. Thus, identifying the molecular mechanisms of miRNAs may effect on the complexity of cancer progression via regulation of gene. In the current study, we utilized real-time PCR to quantify the diction of miR-148b in trail hepatocellular carcinoma (HCC) specimen and normal tissues. Furthermore, we evaluated the relationship of miR-148b and clinicopathological features with survival of HCC patients. Therefore, we evaluated the level of miR-148b expression in 101 HCC patients and also in 40 normal control cases. The result suggested lower expression in tumor tissues than normal control tissues (0.96 ± 0.14; 1.84 ± 0.20, P < 0.05). Our findings suggest that the declined expression of miR-148b can considerably be linked to tumor node metastasis (TNM) stage (stages III and IV; P = 0.021) and vein invasion (P = 0.029). Nevertheless, miR-148b expression was not related to sex (P = 0.674), age (P = 0. 523), size of tumor (P = 0.507), liver cirrhosis, and histologic grade (P = 0.734). Survival analysis showed that low expression was remarkably related to overall survival (P = 0.012). Furthermore, multivariate survival test suggested that decline of miR-148b diction was linked to poor survival in HCC patients. Our results suggested that miR-148b is decreased in HCC. Therefore, we concluded that miR-148b may play its role in the prognosis of HCC.</description><subject>Biomarkers</subject><subject>Liver cancer</subject><subject>MicroRNAs</subject><subject>Pathology</subject><issn>1010-4283</issn><issn>1423-0380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpdkMtOwzAQRS0EoqXwAWyQJTZsAn7G8RKVp1QJCcE6cpxJSUniYCegSnw8LrQbVnMXZ47uDEKnlFxSQtRVoJwplRAqE65iEHtoSgXjCeEZ2Y-ZUJIIlvEJOgphRSKodXqIJixlJBU6m6LvG_fVeViOjRlq12FX4bZ-TqjICmwCLmrXGv8OHlfOYzC-WeMSBrA7-A16MzgLTRMNHlvjbd3FHWy6ErdmjQP4T9ioDO69W3YuDLXFf9JjdFCZJsDJds7Q693ty_whWTzdP86vF0nPuB6SShoNSjNW8FSUFbNgDIGKCFkylokqU1JpwgTYVDHJLUgiVGENVIqXWhE-Qxd_3tjgY4Qw5G0dNp1NB24MOY3rIuVpJiN6_g9dudF3sd0vRSVXekOdbamxaKHMe1_Hi9b57q_8B89kesE</recordid><startdate>201605</startdate><enddate>201605</enddate><creator>Ziari, Katayoun</creator><creator>Zarea, Mojtaba</creator><creator>Gity, Masoumeh</creator><creator>Fayyaz, Amir Farshid</creator><creator>Yahaghi, Emad</creator><creator>Darian, Ebrahim Khodaverdi</creator><creator>Hashemian, Amir Masoud</creator><general>Springer Nature B.V</general><scope>NPM</scope><scope>7T5</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201605</creationdate><title>Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker</title><author>Ziari, Katayoun ; Zarea, Mojtaba ; Gity, Masoumeh ; Fayyaz, Amir Farshid ; Yahaghi, Emad ; Darian, Ebrahim Khodaverdi ; Hashemian, Amir Masoud</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p239t-f5a9e7922b364df2ceaa0ef045d2284f87579024ec67253ce5047bcaef73d9703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biomarkers</topic><topic>Liver cancer</topic><topic>MicroRNAs</topic><topic>Pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ziari, Katayoun</creatorcontrib><creatorcontrib>Zarea, Mojtaba</creatorcontrib><creatorcontrib>Gity, Masoumeh</creatorcontrib><creatorcontrib>Fayyaz, Amir Farshid</creatorcontrib><creatorcontrib>Yahaghi, Emad</creatorcontrib><creatorcontrib>Darian, Ebrahim Khodaverdi</creatorcontrib><creatorcontrib>Hashemian, Amir Masoud</creatorcontrib><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Tumor biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ziari, Katayoun</au><au>Zarea, Mojtaba</au><au>Gity, Masoumeh</au><au>Fayyaz, Amir Farshid</au><au>Yahaghi, Emad</au><au>Darian, Ebrahim Khodaverdi</au><au>Hashemian, Amir Masoud</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker</atitle><jtitle>Tumor biology</jtitle><addtitle>Tumour Biol</addtitle><date>2016-05</date><risdate>2016</risdate><volume>37</volume><issue>5</issue><spage>5765</spage><epage>5768</epage><pages>5765-5768</pages><issn>1010-4283</issn><eissn>1423-0380</eissn><abstract>MicroRNAs (miRNAs) have a large number of various target genes in different cancer types, which may result in many biological functions. Thus, identifying the molecular mechanisms of miRNAs may effect on the complexity of cancer progression via regulation of gene. In the current study, we utilized real-time PCR to quantify the diction of miR-148b in trail hepatocellular carcinoma (HCC) specimen and normal tissues. Furthermore, we evaluated the relationship of miR-148b and clinicopathological features with survival of HCC patients. Therefore, we evaluated the level of miR-148b expression in 101 HCC patients and also in 40 normal control cases. The result suggested lower expression in tumor tissues than normal control tissues (0.96 ± 0.14; 1.84 ± 0.20, P < 0.05). Our findings suggest that the declined expression of miR-148b can considerably be linked to tumor node metastasis (TNM) stage (stages III and IV; P = 0.021) and vein invasion (P = 0.029). Nevertheless, miR-148b expression was not related to sex (P = 0.674), age (P = 0. 523), size of tumor (P = 0.507), liver cirrhosis, and histologic grade (P = 0.734). Survival analysis showed that low expression was remarkably related to overall survival (P = 0.012). Furthermore, multivariate survival test suggested that decline of miR-148b diction was linked to poor survival in HCC patients. Our results suggested that miR-148b is decreased in HCC. Therefore, we concluded that miR-148b may play its role in the prognosis of HCC.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>26206498</pmid><doi>10.1007/s13277-015-3777-4</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1010-4283 |
ispartof | Tumor biology, 2016-05, Vol.37 (5), p.5765-5768 |
issn | 1010-4283 1423-0380 |
language | eng |
recordid | cdi_proquest_miscellaneous_1790463685 |
source | SpringerLink Journals - AutoHoldings |
subjects | Biomarkers Liver cancer MicroRNAs Pathology |
title | Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A18%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Downregulation%20of%20miR-148b%20as%20biomarker%20for%20early%20detection%20of%20hepatocellular%20carcinoma%20and%20may%20serve%20as%20a%20prognostic%20marker&rft.jtitle=Tumor%20biology&rft.au=Ziari,%20Katayoun&rft.date=2016-05&rft.volume=37&rft.issue=5&rft.spage=5765&rft.epage=5768&rft.pages=5765-5768&rft.issn=1010-4283&rft.eissn=1423-0380&rft_id=info:doi/10.1007/s13277-015-3777-4&rft_dat=%3Cproquest_pubme%3E4062893181%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1790153795&rft_id=info:pmid/26206498&rfr_iscdi=true |